WATERTOWN, Mass., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing ...
All master data, key figures and real-time diagram.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback